Citation Impact

Citing Papers

Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Self-Amplifying mRNA Vaccines
2014
IRF-7 is the master regulator of type-I interferon-dependent immune responses
2005 StandoutNature
Progress in human tumour immunology and immunotherapy
2001 Nature
DNA vaccines: a key for inducing long-term cellular immunity
2000
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers
2000
Non-viral gene delivery in skeletal muscle: a protein factory
2003
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Immunotherapeutic uses of CpG oligodeoxynucleotides
2004
Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cells
1996
Protection from Rotavirus Reinfection: 2-Year Prospective Study
1991
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines
2004
A Selenium Analogue of Firefly D ‐Luciferin with Red‐Shifted Bioluminescence Emission
2012 StandoutNobel
Exposing the immunology of naked DNA vaccines
1995
Lymphangiogenesis in development and human disease
2005 StandoutNature
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
2001 StandoutScience
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
A redshifted codon-optimized firefly luciferase is a sensitive reporter for bioluminescence imaging
2008
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Safety and Immunogenicity of Tyrosinase DNA Vaccines in Patients with Melanoma
2007
Self-replicating Semliki Forest virus RNA as recombinant vaccine
1994
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Enhancement of DNA vaccine potency in rhesus macaques by electroporation
2004
Strategies for designing and optimizing new generation vaccines
2001
Vaccines against intracellular infections requiring cellular immunity
2000 Nature
Gene transfer as a tool to induce therapeutic vascular growth
2003
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
2004
Vaccine manufacturing: challenges and solutions
2006
The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?
2002
Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes
2000 StandoutNobel
Stress-induced immune dysfunction: implications for health
2005 Standout
A Plasmid-Based Self-Amplifying Sindbis Virus Vector
1995
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases
2000
Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-α Secretion and Signaling through a Nucleotide Receptor
2002 StandoutNobel
Human Clinical Trials of Plasmid DNA Vaccines
2005
Tumor-targeted gene transfer with DNA polyplexes.
2002
Protection against Rotavirus Disease after Natural Rotavirus Infection
1994
Treatment of murine lupus with cDNA encoding IFN-γR/Fc
2000
Rotavirus Infection in Infants as Protection against Subsequent Infections
1996 Standout
DNA and RNA-based vaccines: principles, progress and prospects
1999
The Preparation, Characterization, and Evaluation of Cationic Microparticles for DNA Vaccine Delivery
2001
Vaccines for the prevention of HIV-1 disease
2001
Immune Recognition of Foreign DNA
1999
Safety, Tolerability, and Lack of Antibody Responses After Administration of a Pf CSP DNA Malaria Vaccine via Needle or Needle-Free Jet Injection, and Comparison of Intramuscular and Combination Intramuscular/Intradermal Routes
2002
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines
2001
Potential of Transfected Muscle Cells to Contribute to DNA Vaccine Immunogenicity
2007
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
DNA-Encoded Fetal Liver Tyrosine Kinase 3 Ligand and Granulocyte Macrophage-Colony-Stimulating Factor Increase Dendritic Cell Recruitment to the Inoculation Site and Enhance Antigen-Specific CD4+ T Cell Responses Induced by DNA Vaccination of Outbred Animals
2002
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice
2000
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Requirement of a Cytoplasmic Fraction for Synthesis of SV40 Deoxyribonucleic Acid in Isolated Nuclei*
1975 StandoutNobel
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen
2001
Cationic microparticles: A potent delivery system for DNA vaccines
2000
Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer
2000
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
1999 StandoutNobel
Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen
2000
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge
2000
Antigen Presentation by Dendritic Cells after Immunization with DNA Encoding a Major Histocompatibility Complex Class II–restricted Viral Epitope
1997 StandoutNobel
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
2001 StandoutNobel
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
2004
Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
2001 StandoutNobel
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines
2004
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine
2001 StandoutNobel
SV40-transformed simian cells support the replication of early SV40 mutants
1981 Standout
Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo
2000 StandoutNobel
Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus
2007
Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo
2000
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
DNA Vaccines: Progress and Challenges
2005
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
The Formation of Immunogenic Major Histocompatibility Complex Class II–Peptide Ligands in Lysosomal Compartments of Dendritic Cells Is Regulated by Inflammatory Stimuli
2000 StandoutNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector
1998
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
2006 StandoutNobel
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood
1990
DNA Vaccines: Immunology, Application, and Optimization
2000
Variation in properties of SV40-transformed simian cell lines detected by superinfection with SV40 and human adenoviruses
1971
In Vivo Priming by DNA Injection Occurs Predominantly by Antigen Transfer
1999
Contribution of Cells at the Site of DNA Vaccination to the Generation of Antigen-Specific Immunity and Memory
1998
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Transformation of green monkey kidney cells by SV40 genome: The establishment of transformed cell lines and the replication of human adenoviruses and SV40 in transformed cells
1971
Tolerogenic Dendritic Cells
2003 StandoutNobel
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.
2000
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses
2004
Gene-based vaccines: recent technical and clinical advances
2006
Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells
2001 StandoutNobel
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques
2007
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
1998 StandoutNobel
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
2004 StandoutNobel
A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expressionin vivo
1995

Works of M Margalith being referenced

Nucleic Acid Malaria Vaccines
1995
Gene Therapy by Intramuscular Injection of Plasmid DNA: Studies on Firefly Luciferase Gene Expression in Mice
1993
Tho Sequential Outbreaks of Rotavirus Gastroenteritis: Evidence for Symptomatic and Asymptomatic Reinfections
1988
Sustained protective rabies neutralizing antibody titers after administration of cationic lipid-formulated pDNA vaccine.
2006
Epstein‐Barr virus specific salivary antibodies as related to stress caused by examinations
2001
DNA Vaccination as an Approach to Malaria Control: Current Status and Strategies
1998
An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal Muscle
1996
Electroporation-Facilitated Delivery of Plasmid DNA in Skeletal Muscle: Plasmid Dependence of Muscle Damage and Effect of Poloxamer 188
2001
In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.
1998
Transformation of BSC1 Cells following Chronic Infection with SV40
1969
Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector.
1996
Characterization of humoral immunity after DNA injection.
1994
Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine
1998 Science
Rankless by CCL
2026